|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 195.75 INR | 0.00% |
|
-3.57% | -5.96% |
| Feb. 13 | Ruchira Papers Limited Announces Board and Committee Changes, Effective January 23 2026 | CI |
| Feb. 06 | Viyash Scientific Limited, Q3 2026 Earnings Call, Feb 06, 2026 |
Company Valuation: Viyash Scientific Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2021 | 2022 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 58,952 | 33,033 | 32,686 | 85,433 | - | - |
| Change | - | -43.97% | - | 161.38% | - | - |
| Enterprise Value (EV) 1 | 58,952 | 33,033 | 32,686 | 88,452 | 87,051 | 85,117 |
| Change | - | -43.97% | - | 170.61% | -1.58% | -2.22% |
| P/E ratio | 62.6x | 81.1x | 154x | - | - | 17.5x |
| PBR | 7.71x | 4.8x | - | - | - | - |
| PEG | - | -1.4x | - | - | - | - |
| Capitalization / Revenue | 4.33x | 2.34x | - | 2.52x | 2.16x | 1.88x |
| EV / Revenue | 4.33x | 2.34x | - | 2.61x | 2.2x | 1.88x |
| EV / EBITDA | 28.9x | 30.2x | - | 14.9x | 12.2x | 10.4x |
| EV / EBIT | - | - | - | - | - | - |
| EV / FCF | - | - | - | 11.3x | 20.9x | 19.5x |
| FCF Yield | - | - | - | 8.82% | 4.78% | 5.14% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | 3.85 | 1.65 | 0.85 | - | - | 11.2 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 13,616 | 14,128 | - | 33,856 | 39,611 | 45,355 |
| EBITDA 1 | 2,037 | 1,094 | - | 5,925 | 7,130 | 8,164 |
| EBIT | 1,531 | 474.7 | - | - | - | - |
| Net income 1 | 954.4 | 412.5 | 218.8 | 2,437 | 4,205 | 5,255 |
| Net Debt 1 | - | - | - | 3,019 | 1,618 | -316 |
| Reference price 2 | 240.90 | 133.80 | 130.80 | 195.75 | 195.75 | 195.75 |
| Nbr of stocks (in thousands) | 244,717 | 246,880 | 249,890 | 436,439 | - | - |
| Announcement Date | 6/30/21 | 5/26/22 | 5/20/25 | - | - | - |
1INR in Million2INR
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | 2.61x | 14.93x | - | 924M | ||
| 28.95x | 10.91x | 21.91x | 0.67% | 880B | ||
| 25.63x | 5.96x | 16.23x | 2.19% | 582B | ||
| 24x | 6.55x | 13.15x | 3.16% | 388B | ||
| 17.32x | 4.22x | 10.43x | 3.13% | 324B | ||
| 23.94x | 4.99x | 13.83x | 1.75% | 295B | ||
| 20.93x | 5.64x | 13.96x | 2.87% | 293B | ||
| 27.02x | 4.74x | 14.82x | 2.92% | 286B | ||
| 24.64x | 6.26x | 11.14x | 2.74% | 197B | ||
| 20.1x | 6.12x | 11.06x | 2.25% | 180B | ||
| Average | 23.61x | 5.80x | 14.15x | 2.41% | 342.71B | |
| Weighted average by Cap. | 24.73x | 6.95x | 15.71x | 2.11% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Equities
- 512529 Stock
- Valuation Viyash Scientific Limited
Select your edition
All financial news and data tailored to specific country editions
















